trial · primary record
AZD4956
Solid Tumours
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 180 |
| Primary completion | 2030-03-29 |
| Primary endpoint | Parts A and B: Number of participants with adverse events (AEs) and serious adverse events (SAEs) |
| Registry ID | NCT07446855 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:19.739Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07446855
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.